Cargando…
Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022): Updated statement of the Austrian Society of Pneumology (ASP)
The Austrian Society of Pneumology (ASP) launched a first statement on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in May 2020, at a time when in Austria 285 people had died from this disease and vaccinations were not available. Lockdown and social distancing were the only...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022736/ https://www.ncbi.nlm.nih.gov/pubmed/35449467 http://dx.doi.org/10.1007/s00508-022-02018-x |
_version_ | 1784690145187856384 |
---|---|
author | Olschewski, Horst Eber, Ernst Bucher, Brigitte Hackner, Klaus Handzhiev, Sabin Hoetzenecker, Konrad Idzko, Marco Klepetko, Walter Kovacs, Gabor Lamprecht, Bernd Löffler-Ragg, Judith Meilinger, Michael Müller, Alexander Prior, Christian Schindler, Otmar Täubl, Helmut Zacharasiewicz, Angela Zwick, Ralf Harun Arns, Britt-Madelaine Bolitschek, Josef Cima, Katharina Gingrich, Elisabeth Hochmair, Maximilian Horak, Fritz Jaksch, Peter Kropfmüller, Roland Pfleger, Andreas Puchner, Bernhard Puelacher, Christoph Rodriguez, Patricia Salzer, Helmut J. F. Schenk, Peter Stelzmüller, Ingrid Strenger, Volker Urban, Matthias Wagner, Marlies Wimberger, Franz Flick, Holger |
author_facet | Olschewski, Horst Eber, Ernst Bucher, Brigitte Hackner, Klaus Handzhiev, Sabin Hoetzenecker, Konrad Idzko, Marco Klepetko, Walter Kovacs, Gabor Lamprecht, Bernd Löffler-Ragg, Judith Meilinger, Michael Müller, Alexander Prior, Christian Schindler, Otmar Täubl, Helmut Zacharasiewicz, Angela Zwick, Ralf Harun Arns, Britt-Madelaine Bolitschek, Josef Cima, Katharina Gingrich, Elisabeth Hochmair, Maximilian Horak, Fritz Jaksch, Peter Kropfmüller, Roland Pfleger, Andreas Puchner, Bernhard Puelacher, Christoph Rodriguez, Patricia Salzer, Helmut J. F. Schenk, Peter Stelzmüller, Ingrid Strenger, Volker Urban, Matthias Wagner, Marlies Wimberger, Franz Flick, Holger |
author_sort | Olschewski, Horst |
collection | PubMed |
description | The Austrian Society of Pneumology (ASP) launched a first statement on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in May 2020, at a time when in Austria 285 people had died from this disease and vaccinations were not available. Lockdown and social distancing were the only available measures to prevent more infections and the breakdown of the health system. Meanwhile, in Austria over 13,000 patients have died in association with a SARS-CoV‑2 infection and coronavirus disease 2019 (COVID-19) was among the most common causes of death; however, SARS-CoV‑2 has been mutating all the time and currently, most patients have been affected by the delta variant where the vaccination is very effective but the omicron variant is rapidly rising and becoming predominant. Particularly in children and young adults, where the vaccination rate is low, the omicron variant is expected to spread very fast. This poses a particular threat to unvaccinated people who are at elevated risk of severe COVID-19 disease but also to people with an active vaccination. There are few publications that comprehensively addressed the special issues with SARS-CoV‑2 infection in patients with chronic lung diseases. These were the reasons for this updated statement. Pulmonologists care for many patients with an elevated risk of death in case of COVID-19 but also for patients that might be at an elevated risk of vaccination reactions or vaccination failure. In addition, lung function tests, bronchoscopy, respiratory physiotherapy and training therapy may put both patients and health professionals at an increased risk of infection. The working circles of the ASP have provided statements concerning these risks and how to avoid risks for the patients. |
format | Online Article Text |
id | pubmed-9022736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-90227362022-04-22 Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022): Updated statement of the Austrian Society of Pneumology (ASP) Olschewski, Horst Eber, Ernst Bucher, Brigitte Hackner, Klaus Handzhiev, Sabin Hoetzenecker, Konrad Idzko, Marco Klepetko, Walter Kovacs, Gabor Lamprecht, Bernd Löffler-Ragg, Judith Meilinger, Michael Müller, Alexander Prior, Christian Schindler, Otmar Täubl, Helmut Zacharasiewicz, Angela Zwick, Ralf Harun Arns, Britt-Madelaine Bolitschek, Josef Cima, Katharina Gingrich, Elisabeth Hochmair, Maximilian Horak, Fritz Jaksch, Peter Kropfmüller, Roland Pfleger, Andreas Puchner, Bernhard Puelacher, Christoph Rodriguez, Patricia Salzer, Helmut J. F. Schenk, Peter Stelzmüller, Ingrid Strenger, Volker Urban, Matthias Wagner, Marlies Wimberger, Franz Flick, Holger Wien Klin Wochenschr Position Paper The Austrian Society of Pneumology (ASP) launched a first statement on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in May 2020, at a time when in Austria 285 people had died from this disease and vaccinations were not available. Lockdown and social distancing were the only available measures to prevent more infections and the breakdown of the health system. Meanwhile, in Austria over 13,000 patients have died in association with a SARS-CoV‑2 infection and coronavirus disease 2019 (COVID-19) was among the most common causes of death; however, SARS-CoV‑2 has been mutating all the time and currently, most patients have been affected by the delta variant where the vaccination is very effective but the omicron variant is rapidly rising and becoming predominant. Particularly in children and young adults, where the vaccination rate is low, the omicron variant is expected to spread very fast. This poses a particular threat to unvaccinated people who are at elevated risk of severe COVID-19 disease but also to people with an active vaccination. There are few publications that comprehensively addressed the special issues with SARS-CoV‑2 infection in patients with chronic lung diseases. These were the reasons for this updated statement. Pulmonologists care for many patients with an elevated risk of death in case of COVID-19 but also for patients that might be at an elevated risk of vaccination reactions or vaccination failure. In addition, lung function tests, bronchoscopy, respiratory physiotherapy and training therapy may put both patients and health professionals at an increased risk of infection. The working circles of the ASP have provided statements concerning these risks and how to avoid risks for the patients. Springer Vienna 2022-04-21 2022 /pmc/articles/PMC9022736/ /pubmed/35449467 http://dx.doi.org/10.1007/s00508-022-02018-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Position Paper Olschewski, Horst Eber, Ernst Bucher, Brigitte Hackner, Klaus Handzhiev, Sabin Hoetzenecker, Konrad Idzko, Marco Klepetko, Walter Kovacs, Gabor Lamprecht, Bernd Löffler-Ragg, Judith Meilinger, Michael Müller, Alexander Prior, Christian Schindler, Otmar Täubl, Helmut Zacharasiewicz, Angela Zwick, Ralf Harun Arns, Britt-Madelaine Bolitschek, Josef Cima, Katharina Gingrich, Elisabeth Hochmair, Maximilian Horak, Fritz Jaksch, Peter Kropfmüller, Roland Pfleger, Andreas Puchner, Bernhard Puelacher, Christoph Rodriguez, Patricia Salzer, Helmut J. F. Schenk, Peter Stelzmüller, Ingrid Strenger, Volker Urban, Matthias Wagner, Marlies Wimberger, Franz Flick, Holger Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022): Updated statement of the Austrian Society of Pneumology (ASP) |
title | Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022): Updated statement of the Austrian Society of Pneumology (ASP) |
title_full | Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022): Updated statement of the Austrian Society of Pneumology (ASP) |
title_fullStr | Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022): Updated statement of the Austrian Society of Pneumology (ASP) |
title_full_unstemmed | Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022): Updated statement of the Austrian Society of Pneumology (ASP) |
title_short | Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022): Updated statement of the Austrian Society of Pneumology (ASP) |
title_sort | management of patients with sars-cov-2 infections with focus on patients with chronic lung diseases (as of 10 january 2022): updated statement of the austrian society of pneumology (asp) |
topic | Position Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022736/ https://www.ncbi.nlm.nih.gov/pubmed/35449467 http://dx.doi.org/10.1007/s00508-022-02018-x |
work_keys_str_mv | AT olschewskihorst managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT eberernst managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT bucherbrigitte managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT hacknerklaus managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT handzhievsabin managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT hoetzeneckerkonrad managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT idzkomarco managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT klepetkowalter managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT kovacsgabor managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT lamprechtbernd managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT lofflerraggjudith managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT meilingermichael managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT mulleralexander managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT priorchristian managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT schindlerotmar managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT taublhelmut managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT zacharasiewiczangela managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT zwickralfharun managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT arnsbrittmadelaine managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT bolitschekjosef managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT cimakatharina managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT gingrichelisabeth managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT hochmairmaximilian managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT horakfritz managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT jakschpeter managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT kropfmullerroland managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT pflegerandreas managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT puchnerbernhard managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT puelacherchristoph managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT rodriguezpatricia managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT salzerhelmutjf managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT schenkpeter managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT stelzmulleringrid managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT strengervolker managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT urbanmatthias managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT wagnermarlies managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT wimbergerfranz managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp AT flickholger managementofpatientswithsarscov2infectionswithfocusonpatientswithchroniclungdiseasesasof10january2022updatedstatementoftheaustriansocietyofpneumologyasp |